Voyageur Pharmaceuticals Ltd (VM) - Total Liabilities

Latest as of November 2025: CA$1.85 Million CAD ≈ $1.34 Million USD

Based on the latest financial reports, Voyageur Pharmaceuticals Ltd (VM) has total liabilities worth CA$1.85 Million CAD (≈ $1.34 Million USD) as of November 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore VM cash flow conversion to assess how effectively this company generates cash.

Voyageur Pharmaceuticals Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Voyageur Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Voyageur Pharmaceuticals Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Voyageur Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Voyageur Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
JOY SPREADER GROUP INC. F:5YN	Germany	€403.07 Million
Hampton Financial Corp V:HFC	Canada	CA$26.32 Million
Omineca Mining and Metals Ltd V:OMM	Canada	CA$13.59 Million
CAM Resources Bhd KLSE:7128	Malaysia	RM40.27 Million
Polyrizon Ltd. Ordinary Shares NASDAQ:PLRZ	USA	$364.00K
Glen Burnie Bancorp NASDAQ:GLBZ	USA	$338.49 Million
Grand Baoxin Auto Group Limited F:6BA	Germany	€13.46 Billion
Vo2 Cap Holding AB ST:VO2	Sweden	Skr122.46 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Voyageur Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Voyageur Pharmaceuticals Ltd (VM) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.48	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Voyageur Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Voyageur Pharmaceuticals Ltd (2011–2025)

The table below shows the annual total liabilities of Voyageur Pharmaceuticals Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-11-30	CA$1.85 Million ≈ $1.34 Million	-13.77%
2024-11-30	CA$2.15 Million ≈ $1.55 Million	+195.16%
2023-11-30	CA$727.88K ≈ $526.54K	+15.38%
2022-11-30	CA$630.83K ≈ $456.33K	-4.51%
2021-11-30	CA$660.64K ≈ $477.89K	-31.81%
2020-11-30	CA$968.85K ≈ $700.85K	+13.62%
2019-11-30	CA$852.69K ≈ $616.82K	+13.57%
2018-11-30	CA$750.79K ≈ $543.11K	-21.72%
2017-11-30	CA$959.12K ≈ $693.81K	+2368.08%
2016-11-30	CA$38.86K ≈ $28.11K	+318.67%
2015-11-30	CA$9.28K ≈ $6.71K	-88.17%
2014-11-30	CA$78.45K ≈ $56.75K	+814.22%
2013-11-30	CA$8.58K ≈ $6.21K	-63.44%
2012-11-30	CA$23.47K ≈ $16.98K	+10.68%
2011-11-30	CA$21.21K ≈ $15.34K	--

About Voyageur Pharmaceuticals Ltd

V:VM Canada Drug Manufacturers - Specialty & Generic

Market Cap

$14.21 Million

CA$19.64 Million CAD

Market Cap Rank

#25996 Global

#1059 in Canada

Share Price

CA$0.11

Change (1 day)

+0.00%

52-Week Range

CA$0.10 - CA$0.34

All Time High

CA$0.34